2 employees
Vivita Technologies develops biomaterials for regenerative medicine, intending to alleviate the scarcity of donor organs and tissues.
$1.5M
from 1 investors over 1 rounds
ViVita Technologies raised $1.5M on September 13, 2022
Investors: National Heart, Lung, and Blood Institute